Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04214301 · ClinicalTrials.gov registry record · Phase 4
An Open-Label Preference Evaluation of BLI800
A Phase 4 study, sponsored by Braintree Laboratories.
- Completed
- Registry status
- Phase 4
- Development phase
- 40
- Enrollment target
NCT04214301 is a Phase 4 study that has completed, run by Braintree Laboratories. The registered enrollment target is 40 participants.
The verdict
NCT04214301, a Phase 4 study, has completed, sponsored by Braintree Laboratories.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.
Interventions
- DRUG BLI800
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2019-09-24 |
| Est. Completion | 2019-11-21 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04214301
The ClinicalTrials.gov registry entry for NCT04214301 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Braintree Laboratories, which has 49 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BLI800 is the first listed.
NCT04214301 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04214301 about?
NCT04214301 is a clinical study titled "An Open-Label Preference Evaluation of BLI800". The purpose of this study is to evaluate patient experience ratings of BLI800 in adult patients undergoing colonoscopy.
What is the current status of trial NCT04214301?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 40 participants. The study started on 2019-09-24. Estimated completion is 2019-11-21.
What interventions are being tested in trial NCT04214301?
The interventions under investigation include: BLI800 (DRUG).
Who is sponsoring clinical trial NCT04214301?
This trial is sponsored by Braintree Laboratories, which has 49 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.